PMV Pharmaceuticals, Inc.
PMVP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $78 | $149 | $397 | $1,043 |
| - Cash | $41 | $38 | $108 | $172 |
| + Debt | $1 | $13 | $14 | $11 |
| Enterprise Value | $38 | $124 | $302 | $881 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | -$74 | -$68 | -$73 | -$57 |
| % Margin | – | – | – | – |
| Net Income | -$59 | -$69 | -$73 | -$58 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.138 | -1.44 | -1.61 | -1.28 |
| % Growth | 21% | 10.6% | -25.8% | – |
| Operating Cash Flow | -$51 | -$56 | -$64 | -$47 |
| Capital Expenditures | -$1 | -$1 | -$8 | -$1 |
| Free Cash Flow | -$52 | -$57 | -$72 | -$48 |